Wilmot Cancer Institute at Webster is a clinical research site located in Webster, New York, United States 14580.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Wilmot Cancer Institute at Webster has participated in 53 clinical trials with 50 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Extensive Stage Lung Small Cell Carcinoma.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group.
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Wilmot Cancer Institute at Webster has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wilmot Cancer Institute at Webster has 53 clinical trials on record, with 50 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Extensive Stage Lung Small Cell Carcinoma.
Yes — Wilmot Cancer Institute at Webster holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.